Achieving Polymorphic and Stoichiometric Diversity in Cocrystal Formation: Importance of Solid-State Grinding, Powder X-ray Structure Determination, and Seeding
Source abstract
Abstract
Solid-state grinding is explored as a means of selectively preparing specific stoichiometric or polymorphic modifications of crystalline supramolecular complexes, or cocrystals. In research involving cocrystals of the model pharmaceutical compound caffeine prepared via solid-state grinding and solution crystallization, it has been demonstrated that these two methods of preparation are not always coterminous with respect to the cocrystal product obtained. Examined herein are the structures of five previously unreported caffeine cocrystals with monocarboxylic acids, including formic acid, acetic acid, and trifluoroacetic acid. This system illustrates three different possibilities in performing cocrystal preparation via the dual methods of solid-state grinding and solution crystallization: (1) the same cocrystal can result from both methods; (2) different cocrystal stoichiometries can result from each method; (3) different cocrystal polymorphs can result from each method. Materials that at first could be prepared only by solid-state grinding were later induced to crystallize from solution by seeding with the grinding material. Because some cocrystals from grinding contained minor residual unreacted starting components, a phase-subtraction method was used to enable subsequent crystal structure determination from powder X-ray diffraction data. The findings herein assign a significance to solid-state grinding as a technique of choice in widespread screening efforts for novel supramolecular materials.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Crystallography and molecular interactions · Crystallization and Solubility Studies · X-ray Diffraction in Crystallography
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Pfizer Institute for Pharmaceutical Materials Science, Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, U.K., and Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, U.K.
References (44)
Show source-provided references
1. Almarsson · J. Chem. Commun. · 2004 · 1889 · 1896
2. Childs S. L. · J. Am. Chem. Soc. · 2004 · 126 · 1334210.1021/ja048114o ↗
3. Remenar J. F. · J. Am. Chem. Soc. · 2003 · 125 · 845710.1021/ja035776p ↗
4. Trask A. V. · Cryst. Growth Des. · 2005 · 5 · 1021
5. Stahl P. H. · 2002
6. Morissette S. L. · Adv. Drug Delivery Rev. · 2004 · 56 · 30010.1016/j.addr.2003.10.020 ↗
7. Trask, A. V.; Jones, W. InTopics in Current Chemistry; Toda, F., Ed.; Springer: Berlin, 2005; Vol. 254, pp 41−70.10.1007/b100995 ↗
8. Ling A. R. · J. Chem. Soc. · 1893 · 63 · 132710.1039/CT8936301327 ↗
9. Etter M. C. · Chem. Commun. · 1990 · 8 · 591
10. Etter M. C. · J. Am. Chem. Soc. · 1991 · 113 · 259810.1021/ja00007a037 ↗
11. Etter M. C. · J. Am. Chem. Soc. · 1993 · 115 · 441210.1021/ja00063a089 ↗
12. Kuroda R. · Chem. Commun. · 2002 · 2848 · 2849
13. Hollingsworth M. D. · J. Chem. Mater. · 1991 · 3 · 2510.1021/cm00013a010 ↗
14. Hollingsworth M. D. · Chem. Mater. · 1994 · 6 · 1244
15. Braga D. · Chem. Commun. · 2002 · 2960 · 2961
16. Cheung E. Y. · J. Am. Chem. Soc. · 2003 · 125 · 14659
17. Caira M. R. · J. Chem. Soc., Perkin Trans. 2 · 1995 · 2213 · 2216
18. Trask A. V. · Chem. Commun. · 2004 · 890 · 891
19. Griesser U. J. · Int. J. Pharm. · 1995 · 120 · 9310.1016/0378-5173(94)00416-3 ↗
20. Edwards H. G. M. · J. Chem. Soc., Perkin Trans. 2 · 1997 · 1985 · 1990
21. 2001
22. David W. I. F. · 2002 · 13
23. Shan N. · Chem. Commun. · 2002 · 2372 · 2373
24. X‘Pert Plus · 1999
25. Otwinowski, Z.; Minor, W. InMacromolecular Crystallography, Part A; Carter Jr., C. W., Sweet, R. M., Eds.; Academic Press: San Diego, CA, 1997; Vol. 276, pp 307−326.10.1016/S0076-6879(97)76066-X ↗
26. Nonius · 1998
27. Blessing R. H. · Acta Crystallogr. · 1995 · 51 · 3810.1107/S0108767394006720 ↗
28. Sheldrick, G.SHELXS-97; University of Göttingen: Germany, 1997.
29. Sheldrick, G.SHELXL-97; University of Göttingen: Germany, 1997.
30. Carlucci L. · Chem.Eur. J. · 2004 · 11 · 279
31. David W. I. F. · Chem. Commun. · 1998 · 931 · 932
32. David W. I. F. · J. Appl. Crystallogr. · 2001 · 34 · 324
33. Boultif A. · J. Appl. Crystallogr. · 1991 · 24 · 99310.1107/S0021889891006441 ↗
34. Markvardsen A. J. · Acta Crystallogr. · 2001 · 57 · 5410.1107/S0108767300012174 ↗
35. DMol3; Accelrys Inc. San Diego, CA, 2004.
36. Allen F. H. · Acta Crystallogr. · 2002 · 58 · 388
37. Had
38. Ojala W. H. · J. Am. Chem. Soc. · 1992 · 114 · 1029310.1021/ja00052a026 ↗
39. Steiner T. · Angew. Chem., Int. Ed. · 2001 · 40 · 265410.1002/1521-3773(20010716)40:14<2654::AID-ANIE2654>3.0.CO;2-L ↗
40. Foces-Foces C. · J. Am. Chem. Soc. · 2001 · 123 · 790610.1021/ja002688l ↗
41. Gilli G. · J. Mol. Struct. · 2000 · 552 · 1510.1016/S0022-2860(00)00454-3 ↗
42. Braga D. · Chem. Commun. · 2004 · 976 · 977
43. Kuroda R. · CrystEngComm · 2004 · 6 · 46810.1039/b408971e ↗
44. Pirttimäki J. · Int. J. Pharm. · 1993 · 95 · 9910.1016/0378-5173(93)90394-U ↗